Form 4: Collegium Pharmaceutical EVP and General Counsel Shirley Kuhlmann Sells Shares
SEC Form 4 Filing
Shirley Kuhlmann, EVP and General Counsel of Collegium Pharmaceutical, sold shares of common stock in multiple transactions on September 5th and 6th, 2024.
Summary
- Shirley R. Kuhlmann, EVP and General Counsel of Collegium Pharmaceutical, sold shares of the company's common stock.
- The transactions occurred on September 5th and 6th, 2024.
- On September 5th, 16,848 shares were sold at a weighted average price of $38.18, and 2,400 shares were sold at a weighted average price of $39.1421.
- On September 6th, 977 shares were sold at a weighted average price of $37.4556.
- Following these transactions, Kuhlmann directly owns 119,184 shares of Collegium Pharmaceutical common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of share sales by an executive. The sales themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider. It provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of first reported transaction: sale of 16,848 shares at $38.18 and 2,400 shares at $39.1421. |
| 09/06/2024 | Date of second reported transaction: sale of 977 shares at $37.4556. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.